Secondary analysis of the FAVORIT data in kidney transplant recipients showed that systolic blood pressure ≥140 mmHg and diastolic blood pressure <70 mmHg at trial entry were associated with increased risks of cardiovascular disease over a mean of 4 years. Whether these blood pressure values are associated with mortality is unclear.
This is a preview of subscription content, log in via an institution to check access.
References
Carpenter, M. A. et al. BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation Trial. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2013040435.
Bostom, A. G. et al. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation 123, 1763–1770 (2011).
Jardine, A. G. et al. Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study. Am. J. Transplant. 4, 988–995 (2004).
Briet, M., Boutouyrie, P., Laurent, S. & London, G. M. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int. 82, 388–400 (2012).
Bahous, S. A., Stephan, A., Blacher, J. & Safar, M. E. Aortic stiffness, living donors, and renal transplantation. Hypertension 47, 216–221 (2006).
Delahousse, M. et al. Aortic stiffness of kidney transplant recipients correlates with donor age. J. Am. Soc. Nephrol. 19, 798–805 (2008).
Philipp, T. et al. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Nephrol. Dial. Transplant. 25, 967–976 (2010).
Lentine, K. L., Axelrod, D. & Abbott, K. C. Interpreting body composition in kidney transplantation: weighing candidate selection, prognostication, and interventional strategies to optimize health. Clin. J. Am. Soc. Nephrol. 6, 1238–1240 (2011).
James, P. A. et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311, 507–520 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Lentine, K., Brennan, D. The relevance of the FAVORIT blood pressure associations. Nat Rev Nephrol 10, 366–367 (2014). https://doi.org/10.1038/nrneph.2014.79
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2014.79
- Springer Nature Limited